跳至主要内容
临床试验/KCT0002170
KCT0002170招募中未知

Moxibustion for treating cancer-related fatigue: a multicenter, assessor-blinded, randomized controlled clinical trial

Korea Institute of Oriental Medicine0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 79(Year)(—)
性别
All

入选标准

  • 1. Both male and female, aged 19 or over, but under 80 years
  • 2. Cessation of cancer-related treatments (e.g. surgery, chemotherapy, radiotherapy, immunotherapy, except for on-going hormone therapy, which must have been initiated at least 3 weeks prior to enrollment) at least 12 weeks before the trial
  • 3. Continuous fatigue related to cancer treatment or cancer itself for at least 4 weeks, fulfilment of The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnostic criteria for cancer-related fatigue, and 4 and higher points in a Brief Fatigue Inventory (BFI) score
  • 4. The Eastern Cooperative Oncology Group (ECOG) performance status = 2
  • 5. Willingness to participate in the trial and provide written consent

排除标准

  • 1. Current level of fatigue even before the diagnosis of cancer
  • 2. Severe anemia (platelet count < 60,000/µL, or hemoglobin < 8 g/dL, or absolute neutrophil count < 1,000)
  • 3. Receiving aggressive treatment for anemia (e.g. erythropoietin or blood transfusion)
  • 4. Poor oral intake with a lower-than-normal level of serum albumin
  • 5. Any significant sign or symptom of inflammation with C-reactive protein = 10 mg/L and white blood cell > 10,000/µL
  • 6. Abnormal findings in thyroid function test (abnormal level of Free thyroxine [free T4] and thyroid stimulating hormone [TSH] < 0.1 uIU/ml or TSH > 5.1 uIU/ml)
  • 7. Abnormal findings in liver function test or renal function test, or serious liver failure or renal failure
  • (aspartate aminotransferase or alanine aminotransferase = 2 x upper normal range, or creatinine = 2.0 mg/dL)
  • 8. A score of 11 points and over in subscale of anxiety or depression in Hospital Anxiety and Depression Scale (HADS)
  • 9. A score of 15 points and over in insomnia severity index (ISI)
  • 10. Level of cancer pain measured by numeric rating scale = 4
  • 11. Six months or less life expectancy
  • 12. A plan of surgery, chemotherapy, radiotherapy during the study
  • 13. Past history of medication (methylphenidate, modafinil, bupropion, dexamethasone) to manage cancer-related fatigue at least 4 weeks before the trial
  • 14. Past history of Korean medical treatment (e.g. acupuncture, moxibustion, cupping, or herbal medicine, etc.) to manage cancer-related fatigue at least 4 weeks before the trial
  • 15. Past history in the preivous 4 weeks or a new plan during the study of initiating dietary supplements or non-pharmacologic therapies (e.g. cognitive behavioral therapy, exercise etc.) to alleviate cancer-related fatigue
  • 16. Having participated in other clinical trial in the precious 4 weeks
  • 17. Past history of hypersensitivity reactions or serious adverse reactions after moxibustion treatment or an inability to cooperate with moxibustion treatment due to some reasons such as dyspnea
  • 18. Women who are pregnant, lactating, or planning to become pregnant
  • 19. Presence of other apparent factors or any diseases that could cause the current fatigue other than cancer treatment or cancer itself

研究者

相似试验

Moxibustion for treating cancer-related fatigue: a... | 临床试验